Total Payments
$120,768
2024 Payments
$12,692
Companies
48
Transactions
810
Medicare Patients
5,117
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$94,238 (78.0%)
Food & Beverage$13,433 (11.1%)
Travel$8,399 (7.0%)
Consulting$4,350 (3.6%)
Education$345.70 (0.3%)
Gifts$1.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $94,238 | 75 | 78.0% |
| Food and Beverage | $13,433 | 683 | 11.1% |
| Travel and Lodging | $8,399 | 41 | 7.0% |
| Consulting Fee | $4,350 | 2 | 3.6% |
| Education | $345.70 | 8 | 0.3% |
| Gift | $1.77 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $47,862 | 92 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $37,457 | 139 | $0 (2024) |
| Amgen Inc. | $24,267 | 69 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $2,385 | 12 | $0 (2018) |
| CSL Behring | $1,817 | 7 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $949.84 | 127 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $673.56 | 38 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $574.93 | 26 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $518.21 | 36 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $408.81 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,692 | 95 | AstraZeneca Pharmaceuticals LP ($9,896) |
| 2023 | $9,973 | 85 | AstraZeneca Pharmaceuticals LP ($9,002) |
| 2022 | $5,337 | 97 | Amgen Inc. ($3,589) |
| 2021 | $11,107 | 137 | AstraZeneca Pharmaceuticals LP ($9,443) |
| 2020 | $10,685 | 75 | AstraZeneca Pharmaceuticals LP ($8,282) |
| 2019 | $21,969 | 121 | Otsuka America Pharmaceutical, Inc. ($13,733) |
| 2018 | $20,908 | 98 | Otsuka America Pharmaceutical, Inc. ($19,477) |
| 2017 | $28,096 | 102 | Otsuka America Pharmaceutical, Inc. ($12,433) |
All Payment Transactions
810 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: CRITICAL CARE | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Cardio-renal | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEPHROLOGY | ||||||
| 10/25/2024 | CSL Behring | — | Travel and Lodging | Cash or cash equivalent | $347.51 | General |
| 10/22/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $443.00 | General |
| 10/17/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $151.28 | General |
| 10/17/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $35.75 | General |
| 10/17/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $28.60 | General |
| 10/16/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $659.55 | General |
| 10/16/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $151.28 | General |
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Cardio-renal | ||||||
| 10/02/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: DIABETES | ||||||
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,029 | 1,943 | $333,159 | $203,320 |
| 2022 | 15 | 1,173 | 2,256 | $397,411 | $243,409 |
| 2021 | 18 | 1,420 | 2,810 | $480,973 | $310,010 |
| 2020 | 22 | 1,495 | 27,318 | $530,764 | $320,319 |
Total Patients
5,117
Total Services
34,327
Medicare Billing
$1.1M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 318 | 644 | $112,700 | $62,437 | 55.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 86 | 155 | $62,900 | $46,121 | 73.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 212 | 606 | $63,990 | $40,506 | 63.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 119 | 132 | $40,200 | $18,887 | 47.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 66 | $13,250 | $9,007 | 68.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 67 | $8,844 | $6,751 | 76.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 52 | 101 | $9,725 | $6,093 | 62.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $8,830 | $5,613 | 63.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 20 | $7,500 | $5,003 | 66.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $1,975 | $1,322 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $1,625 | $836.29 | 51.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 17 | $850.00 | $327.84 | 38.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 31 | $320.00 | $260.40 | 81.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 45 | $450.00 | $153.45 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 331 | 678 | $118,650 | $65,884 | 55.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 92 | 211 | $85,900 | $63,375 | 73.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 239 | 681 | $71,885 | $40,176 | 55.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 140 | 153 | $46,400 | $24,856 | 53.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 29 | 36 | $13,575 | $9,028 | 66.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 60 | $12,050 | $8,480 | 70.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 49 | 49 | $12,740 | $8,448 | 66.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 93 | $12,366 | $7,823 | 63.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 59 | 125 | $11,645 | $7,591 | 65.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 35 | $5,425 | $3,763 | 69.4% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2022 | 18 | 32 | $3,680 | $2,809 | 76.3% |
About Dr. Kenneth Liss, DO
Dr. Kenneth Liss, DO is a Nephrology healthcare provider based in Eatontown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033125315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Liss, DO has received a total of $120,768 in payments from pharmaceutical and medical device companies, with $12,692 received in 2024. These payments were reported across 810 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($94,238).
As a Medicare-enrolled provider, Liss has provided services to 5,117 Medicare beneficiaries, totaling 34,327 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Eatontown, NJ
- Active Since 07/31/2006
- Last Updated 03/08/2024
- Taxonomy Code 246ZN0300X
- Entity Type Individual
- NPI Number 1033125315
Products in Payments
- JYNARQUE (Drug) $30,014
- LOKELMA (Drug) $20,155
- Parsabiv (Biological) $18,731
- SAMSCA (Drug) $17,863
- FARXIGA (Drug) $16,952
- Parsabiv (Drug) $3,688
- Auryxia (Drug) $2,443
- Sensipar (Drug) $1,616
- Edarbi (Drug) $670.02
- LUPKYNIS (Drug) $574.93
- Veltassa (Drug) $569.05
- Velphoro (Drug) $500.35
- ACTHAR (Biological) $497.57
- RAYALDEE (Drug) $463.23
- Kerendia (Drug) $408.81
- KRYSTEXXA (Biological) $362.75
- INJECTAFER (Drug) $354.57
- Rayaldee (Drug) $195.16
- NORTHERA (Drug) $184.83
- Edarbyclor (Drug) $183.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.